CBIO vs STLD · $491.3M cap vs P/E 29, rev $17.54B
Crescent Biopharma, Inc. (CBIO) versus Steel Dynamics Inc (STLD) — a side-by-side from cached financials, not a winner call.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
Steel Dynamics Inc (STLD) is a steel company listed on NASDAQ.
CBIO does not have a complete income-statement cache yet.
Latest reported STLD revenue for 2024-12-31 was $17.54B. Net income was $1.55B. Revenue was down 6.7% from 2023-12-31 to 2024-12-31. STLD currently screens at market cap $38.96B and trailing P/E 29.0.
CBIO currently screens at market cap $491.3M. STLD currently screens at market cap $38.96B and trailing P/E 29.0.
Not investment advice. Open the CBIO and STLD stock pages for the full models.
Not investment advice.